For Novo Nordisk, this century-old grudge match was also personal
December 12, 2024: Judge Approves Schedule for Upcoming Motions in Federal Ozempic MDL On December 3, 2024, the federal Judge handling the massive case against the makers of Ozempic entered a scheduling order to set deadlines for the defendants motions to dismiss
Cells were incubated with Cd45-FITC (rat IgG), Cd11b-(Mac1)-PECy7 (rat IgG2b,), and Ly6g-PE (rat IgG2a,) antibodies (Supplementary Data 1) for 20 min at RT
And so, now all of a sudden you get to a point where healthcare starts becoming not only transparent but deterministic
The approval was granted based on the results of the Phase III CheckMate -76K trial, where Opdivo reduced the risk of recurrence, new primary melanoma or death by 58% compared to placebo